{"id":"fibrinogen-human-tachosil","safety":{"commonSideEffects":[{"rate":null,"effect":"Infection at surgical site"},{"rate":null,"effect":"Seroma formation"},{"rate":null,"effect":"Hematoma"},{"rate":null,"effect":"Allergic reaction"}]},"_chembl":{"chemblId":"CHEMBL2109072","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"TachoSil consists of a collagen patch coated with human fibrinogen and human thrombin. When applied to bleeding surfaces, the thrombin activates the fibrinogen to form fibrin, which polymerizes and creates a mechanical seal. This provides rapid hemostasis and adhesion at surgical sites, reducing bleeding and promoting tissue adhesion.","oneSentence":"TachoSil is a fibrin sealant that provides hemostasis by combining human fibrinogen and thrombin to form a stable fibrin clot at the surgical site.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:12:35.586Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hemostasis in surgical procedures"},{"name":"Tissue adhesion in cardiac, vascular, and general surgery"}]},"trialDetails":[{"nctId":"NCT05385952","phase":"NA","title":"GATT-Patch Versus TachoSil in Liver Surgery","status":"COMPLETED","sponsor":"GATT Technologies BV","startDate":"2022-08-04","conditions":"Intraoperative Bleeding, Hemorrhage, Surgical, Liver Diseases","enrollment":132},{"nctId":"NCT07216157","phase":"NA","title":"NoSeal Trial: Comparing Sealants Versus No Sealant for Preventing CSF Leak After Endonasal Skull Base Surgery","status":"RECRUITING","sponsor":"Maria Sklodowska-Curie National Research Institute of Oncology","startDate":"2025-08-15","conditions":"CerebroSpinal Fluid (CSF) Leak","enrollment":225},{"nctId":"NCT04660721","phase":"PHASE1, PHASE2","title":"A Study Evaluating the Safety and Preliminary Efficacy of sFilm-FS in Controlling Parenchymal Bleeding During Elective Hepatic Surgery","status":"COMPLETED","sponsor":"Sealantium Medical Ltd.","startDate":"2021-05-12","conditions":"Hemostasis, General Surgery","enrollment":33},{"nctId":"NCT05986201","phase":"","title":"Assessment of Long-term Effects of Tachosil","status":"COMPLETED","sponsor":"University of Catania","startDate":"2016-02-01","conditions":"Fibrin Sealant, Haemostasis","enrollment":40},{"nctId":"NCT04065880","phase":"NA","title":"Neoveil® Versus TachoSil® for the Treatment of Pulmonary Air Leaks Following Lung Operation","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2020-04-01","conditions":"Prolonged Air Leak, Postoperative Air Leak","enrollment":46},{"nctId":"NCT05717335","phase":"","title":"Observational Pilot Study With TachoSil as a Ventricular Sealant","status":"COMPLETED","sponsor":"Germans Trias i Pujol Hospital","startDate":"2022-05-01","conditions":"Intraventricular Neoplasm","enrollment":20},{"nctId":"NCT02685007","phase":"","title":"RollOut -Pre-Rolled TachoSil in Laparoscopic Utilisation. A Non-Interventional Study","status":"COMPLETED","sponsor":"Takeda","startDate":"2016-04-05","conditions":"Laparoscopy","enrollment":131},{"nctId":"NCT02311543","phase":"PHASE3","title":"Impact of a Surgical Sealing Patch on Lymphatic Drainage After ALND for Breast Cancer","status":"COMPLETED","sponsor":"Swiss Cancer Institute","startDate":"2015-03-18","conditions":"Breast Cancer","enrollment":142},{"nctId":"NCT02284256","phase":"PHASE3","title":"A Safety and Efficacy Study Comparing Fibrocaps and Tachosil in Hepatic Surgery","status":"COMPLETED","sponsor":"Mallinckrodt","startDate":"2014-11","conditions":"Surgical Bleeding","enrollment":150},{"nctId":"NCT01500135","phase":"PHASE3","title":"Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular Surgery","status":"COMPLETED","sponsor":"Takeda","startDate":"2012-03","conditions":"Bleeding","enrollment":150},{"nctId":"NCT01920958","phase":"","title":"Use of Tachosil® for Lymph Sealing During Surgery","status":"COMPLETED","sponsor":"Takeda","startDate":"2012-09","conditions":"Lymph Node Resection","enrollment":233},{"nctId":"NCT02105506","phase":"NA","title":"Safety and Feasibility of TachoSil®: Application on Esophageal Anastomoses","status":"COMPLETED","sponsor":"R. van Hillegersberg","startDate":"2012-09","conditions":"Esophageal Disease, Gastric Disease","enrollment":15},{"nctId":"NCT00241163","phase":"PHASE3","title":"TachoComb S Versus Standard Surgical Treatment in Surgical Resection of Renal Tumour (TC-015-IN)","status":"COMPLETED","sponsor":"Takeda","startDate":"","conditions":"Surgical Resection of Superficial Renal Tumour","enrollment":170},{"nctId":"NCT00713661","phase":"PHASE2","title":"Evaluation of TachoSil® Application on a Colorectal Anastomosis (TC-029-IM)","status":"COMPLETED","sponsor":"Nycomed","startDate":"2008-06","conditions":"Colorectal Anastomosis","enrollment":25},{"nctId":"NCT00440401","phase":"PHASE4","title":"TachoSil® Versus Standard Haemostatic Treatment of Haemorrhage in Cardiovascular Surgery (TC-023-IM)","status":"COMPLETED","sponsor":"Nycomed","startDate":"2007-02","conditions":"Haemorrhage, Haemostasis, Cardiovascular Surgery","enrollment":120},{"nctId":"NCT00293514","phase":"PHASE3","title":"TachoSil Versus Standard Surgical Treatment for Air Leakage in Pulmonary Lobectomy (TC-021-IM)","status":"COMPLETED","sponsor":"Nycomed","startDate":"2006-02","conditions":"Pulmonary Diseases, Intraoperative Complications","enrollment":""},{"nctId":"NCT00279383","phase":"","title":"OSHES - Observational Study on Hemostasis in Surgery (TC-022-IT)","status":"COMPLETED","sponsor":"Nycomed","startDate":"2005-08","conditions":"Blood Loss, Surgical, Hemostasis","enrollment":800},{"nctId":"NCT00365248","phase":"PHASE3","title":"TachoSil Paediatric Liver Trial (TC-019-IN)","status":"COMPLETED","sponsor":"Nycomed","startDate":"2005-10","conditions":"Liver Diseases","enrollment":16},{"nctId":"NCT00285623","phase":"","title":"Observational Cohort Study of TachoSil (TC-018-IN)","status":"COMPLETED","sponsor":"Nycomed","startDate":"2005-12","conditions":"Blood Loss, Surgical","enrollment":3000},{"nctId":"NCT00546169","phase":"","title":"Non-interventional Trial About Treatment of Haemorrhages in Cholecystectomy With TachoSil (TC-027-DE)","status":"COMPLETED","sponsor":"Nycomed","startDate":"2007-06","conditions":"Hemorrhage","enrollment":500}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":180,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Fibrinogen human (TachoSil)","genericName":"Fibrinogen human (TachoSil)","companyName":"Nycomed","companyId":"nycomed","modality":"Small molecule","firstApprovalDate":"","aiSummary":"TachoSil is a fibrin sealant that provides hemostasis by combining human fibrinogen and thrombin to form a stable fibrin clot at the surgical site. Used for Hemostasis in surgical procedures, Tissue adhesion in cardiac, vascular, and general surgery.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}